Related Experiment Video
Updated: May 30, 2026

10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Malignant carotid body tumor with systemic metastases
Hironobu Nishijima1, Takahiro Asakage, Masashi Sugasawa
1Department of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
The Annals of Otology, Rhinology, and Laryngology
|July 22, 2011
Summary
Malignant carotid body tumors (CBTs) rarely metastasize, often presenting unpredictably. This case highlights histopathologic confirmation of distant metastases in a malignant CBT, emphasizing diagnostic challenges.
Area of Science:
- Oncology
- Pathology
- Head and Neck Surgery
Background:
- Carotid body tumors (CBTs) are rare neoplasms originating from the carotid body.
- While most CBTs are benign, a subset exhibits malignant potential with unpredictable clinical behavior.
- Malignant CBTs are often diagnosed late, through recurrence, metastasis, or distant spread.
Observation:
- This report details a rare instance of a malignant carotid body tumor with confirmed distant metastases.
- The diagnosis was established through rigorous histopathologic examination.
- The case underscores the challenges in correlating histologic findings with clinical behavior in malignant CBTs.
Findings:
- Malignant carotid body tumors can present with distant metastases, despite infrequent reports.
- Histopathology is crucial for confirming the malignant nature and metastatic spread of CBTs.
- The unpredictable nature of malignant CBTs necessitates high clinical suspicion.
Implications:
- This case contributes to the limited literature on histopathologically confirmed malignant CBTs with distant spread.
- Accurate diagnosis and understanding of malignant CBT behavior are vital for patient management.
- Further research into the pathogenesis and prognostic factors of malignant CBTs is warranted.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

